|
Video: What is a Stock Split?
|
|
Twist Bioscience is a synthetic biology and genomics company. Co. has developed multiple products derived from synthetic DNA and its versatile DNA synthesis technology. Co.'s offering consists of two product lines, synthetic biology tools and next generation sequencing (NGS) tools, that address different needs of its customers across various applications. In addition to DNA, Co. provides RNA and protein products. Co.'s synthetic biology products include: synthetic genes and gene fragments, Oligonucleotide, and Immunoglobulin G proteins. Co.'s NGS products are primarily used within diagnostic tests for various indications including rare disease, SARS-CoV-2 and cancer through liquid biopsy. According to our Twist Bioscience stock split history records, Twist Bioscience has had 0 splits. | |
|
Twist Bioscience (TWST) has 0 splits in our Twist Bioscience stock split history database.
Looking at the Twist Bioscience stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Twist Bioscience shares, starting with a $10,000 purchase of TWST, presented on a split-history-adjusted basis factoring in the complete Twist Bioscience stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/01/2018 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$14.10 |
|
End price/share: |
$34.31 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
143.33% |
|
Average Annual Total Return: |
17.87% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$24,331.26 |
|
Years: |
5.41 |
|
|
|
|
|